DVAX

DVAX

Dynavax Technologies Corporation Common Stock

$10.400+0.000 (0.000%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$10.400

Máximo

$10.400

Mínimo

$10.400

Volumen

1.30M

Fundamentos de la Empresa

Estadísticas de Negociación

Noticias Relacionadas

PR Newswire

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

Ver más
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
BusinessWire

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Deep Track's Nominees Are Prepared to Collectively Enter the Boardroom with Open-Minded Perspectives, Constructive Approach and Sole Focus on Creating Value for All Shareholders Believes that Without Meaningful Board

Ver más
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
PR Newswire

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

Ver más
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
PR Newswire

Dynavax Comments on Glass Lewis Recommendation

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

Ver más
Dynavax Comments on Glass Lewis Recommendation
BusinessWire

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Glass Lewis Recommends Shareholders Vote FOR Deep Track Nominees Brett Erkman and Donald Santel and AGAINST Chairman Scott Myers and Director Brent MacGregor Notes that "Deep Track has Highlighted Valid and Critical

Ver más
Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies
PR Newswire

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...

BusinessWire

Deep Track Capital Comments on ISS Recommendation

Strongly Disagrees with Recommendation and Believes ISS Ignored Key Issues in Its Incomplete Analysis ISS Has Chosen Not to Hold the Board Accountable for Its Underperformance in Recent Years, Heplisav's Waning Market